Trial Site Detail

 

Drug:
Ripretinib
Trial:
A Phase 3 Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib (INSIGHT)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Yale University School of Medicine

333 Cedar St     
New Haven , CT 06510
USA

 

Principal Investigator:
Contact:
Activation Status of this Site:
Active
Notes about this Site:
Yale University School of Medicine Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.